Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18
"Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A vaccine containing L1 capsid proteins from four types of HPV (ALPHAPAPILLOMAVIRUS), types 6, 11, 16 and 18 that is used to prevent infections from HUMAN PAPILLOMAVIRUSES of these subtypes.
| Descriptor ID |
D000068857
|
| MeSH Number(s) |
D20.215.894.899.498.500
|
| Concept/Terms |
Human Papillomavirus Vaccine L1, Type 6,11,16,18- Human Papillomavirus Vaccine L1, Type 6,11,16,18
- HPV L1 Vaccine, Quadrivalent 6,11,16,18
|
Below are MeSH descriptors whose meaning is more general than "Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18".
Below are MeSH descriptors whose meaning is more specific than "Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18".
This graph shows the total number of publications written about "Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18" by people in this website by year, and whether "Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2011 | 0 | 1 | 1 |
| 2013 | 0 | 2 | 2 |
| 2015 | 4 | 0 | 4 |
| 2017 | 2 | 0 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18" by people in Profiles.
-
Maternal and Infant Outcomes After Human Papillomavirus Vaccination in the Periconceptional Period or During Pregnancy. Obstet Gynecol. 2017 09; 130(3):599-608.
-
Human papillomavirus vaccine series completion in boys before and after recommendation for routine immunization. Vaccine. 2017 02 07; 35(6):897-902.
-
Absence of venous thromboembolism risk following quadrivalent human papillomavirus vaccination, Vaccine Safety Datalink, 2008-2011. Vaccine. 2016 Jan 02; 34(1):167-71.
-
Quadrivalent Human Papillomavirus Vaccine Initiation in Boys Before and Since Routine Use: Southern California, 2009-2013. Am J Public Health. 2015 Dec; 105(12):2549-56.
-
Unmasking in an observational vaccine safety study: Using type 2 diabetes mellitus as an example. Vaccine. 2015 Nov 17; 33(46):6224-6.
-
An Overview of Quadrivalent Human Papillomavirus Vaccine Safety: 2006 to 2015. Pediatr Infect Dis J. 2015 Sep; 34(9):983-91.
-
Uptake, coverage, and completion of quadrivalent human papillomavirus vaccine in the vaccine safety Datalink, July 2006-June 2011. J Adolesc Health. 2013 Nov; 53(5):637-41.
-
Quadrivalent human papillomavirus vaccine uptake in adolescent boys and maternal utilization of preventive care and history of sexually transmitted infections. Am J Public Health. 2013 Sep; 103(9):e63-8.
-
Surveillance of autoimmune conditions following routine use of quadrivalent human papillomavirus vaccine. J Intern Med. 2012 Feb; 271(2):193-203.